EHP-101
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-128872-5 mg |
| CAS # | 1818428-24-8 |
| Pricing | 5 mg, USD $350.0 |
| Synonyms | VCE-004.8 |
| MWt | 433.58 |
| Formula | C₂₈H₃₅NO₃ |
| Biological Activity | EHP-101 (VCE-004.8) is an orally active, specific PPARγ and CB2 receptor dual agonist. EHP-101 inhibits prolyl-hydroxylases (PHDs) and activates the HIF pathway. EHP-101, a semi-synthetic multitarget cannabinoquinoid, has potent anti-inflammatory activity. EHP-101 attenuates adipogenesis and prevents diet-induced obesity[1][2]. |
| Purity | 98.56% |